Marvin Guinyu Chang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Point-of-Care Systems | 7 | 2025 | 1240 | 1.740 |
Why?
|
Blood Coagulation Disorders | 2 | 2021 | 350 | 1.160 |
Why?
|
Pneumonia, Viral | 10 | 2021 | 3241 | 1.120 |
Why?
|
Coronavirus Infections | 9 | 2020 | 3118 | 1.070 |
Why?
|
Ultrasonography | 8 | 2025 | 6002 | 1.040 |
Why?
|
Intubation, Intratracheal | 3 | 2023 | 1359 | 0.970 |
Why?
|
Arrhythmias, Cardiac | 7 | 2021 | 2258 | 0.730 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7460 | 0.730 |
Why?
|
Electroconvulsive Therapy | 1 | 2024 | 504 | 0.620 |
Why?
|
Pandemics | 10 | 2021 | 8749 | 0.600 |
Why?
|
Equipment and Supplies | 1 | 2020 | 274 | 0.580 |
Why?
|
Thrombosis | 2 | 2021 | 2956 | 0.550 |
Why?
|
Perioperative Care | 1 | 2024 | 1045 | 0.540 |
Why?
|
Myocytes, Cardiac | 6 | 2021 | 1682 | 0.520 |
Why?
|
Critical Illness | 6 | 2021 | 2754 | 0.490 |
Why?
|
Thromboembolism | 1 | 2021 | 1004 | 0.480 |
Why?
|
Lung | 3 | 2024 | 10099 | 0.460 |
Why?
|
Heart Arrest | 1 | 2024 | 1515 | 0.450 |
Why?
|
Action Potentials | 7 | 2021 | 1838 | 0.450 |
Why?
|
Pinacidil | 1 | 2012 | 10 | 0.430 |
Why?
|
Heart-Assist Devices | 2 | 2024 | 1292 | 0.420 |
Why?
|
KATP Channels | 1 | 2012 | 49 | 0.410 |
Why?
|
Heart Ventricles | 6 | 2025 | 3840 | 0.400 |
Why?
|
Heart Conduction System | 3 | 2012 | 1009 | 0.380 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2021 | 775 | 0.360 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2025 | 1483 | 0.310 |
Why?
|
Echocardiography | 1 | 2020 | 5047 | 0.290 |
Why?
|
Airway Management | 2 | 2020 | 326 | 0.270 |
Why?
|
Anticoagulants | 1 | 2021 | 4850 | 0.250 |
Why?
|
Tachycardia, Ventricular | 2 | 2011 | 1309 | 0.230 |
Why?
|
Nitric Oxide | 3 | 2023 | 2149 | 0.230 |
Why?
|
Respiratory Insufficiency | 2 | 2023 | 1241 | 0.220 |
Why?
|
Dobutamine | 1 | 2021 | 116 | 0.190 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.190 |
Why?
|
Torsades de Pointes | 2 | 2012 | 78 | 0.190 |
Why?
|
Voltage-Sensitive Dye Imaging | 2 | 2011 | 30 | 0.180 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2006 | 507 | 0.180 |
Why?
|
Rats | 7 | 2021 | 23786 | 0.160 |
Why?
|
Heart Failure | 2 | 2024 | 11879 | 0.160 |
Why?
|
Calcium Channels, L-Type | 2 | 2012 | 244 | 0.160 |
Why?
|
Humans | 35 | 2025 | 768970 | 0.160 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 375 | 0.150 |
Why?
|
Wound Healing | 1 | 2009 | 2815 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2024 | 1138 | 0.150 |
Why?
|
Tomography | 1 | 2020 | 442 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Acetaminophen | 1 | 2021 | 556 | 0.140 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2020 | 278 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 453 | 0.130 |
Why?
|
Esophagus | 1 | 2022 | 1043 | 0.130 |
Why?
|
Models, Biological | 1 | 2012 | 9499 | 0.130 |
Why?
|
Electric Impedance | 1 | 2020 | 795 | 0.130 |
Why?
|
Animals, Newborn | 3 | 2012 | 2683 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2021 | 965 | 0.120 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 644 | 0.120 |
Why?
|
Connexin 43 | 2 | 2006 | 202 | 0.120 |
Why?
|
Respiration | 1 | 2021 | 1668 | 0.120 |
Why?
|
Administration, Inhalation | 3 | 2023 | 1169 | 0.120 |
Why?
|
Device Removal | 1 | 2019 | 643 | 0.120 |
Why?
|
Lung Diseases | 1 | 2024 | 1944 | 0.110 |
Why?
|
Anesthesiology | 1 | 2024 | 1137 | 0.110 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2020 | 802 | 0.110 |
Why?
|
Hemodynamics | 1 | 2024 | 4199 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
Heart | 2 | 2020 | 4447 | 0.100 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2012 | 34 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3968 | 0.100 |
Why?
|
Isoproterenol | 1 | 2012 | 398 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2080 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3110 | 0.100 |
Why?
|
Electric Conductivity | 1 | 2012 | 408 | 0.090 |
Why?
|
Body Surface Potential Mapping | 1 | 2012 | 228 | 0.090 |
Why?
|
Seizures | 1 | 2024 | 3000 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.080 |
Why?
|
Calcium | 2 | 2021 | 5792 | 0.080 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 691 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3438 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3466 | 0.080 |
Why?
|
Potassium Channel Blockers | 1 | 2009 | 162 | 0.080 |
Why?
|
Anesthesia | 1 | 2020 | 1596 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1542 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2020 | 1947 | 0.080 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 537 | 0.080 |
Why?
|
Sodium Channel Blockers | 1 | 2009 | 173 | 0.080 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2009 | 553 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2190 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11521 | 0.080 |
Why?
|
Atrioventricular Block | 1 | 2010 | 141 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2394 | 0.080 |
Why?
|
Sodium Channels | 1 | 2009 | 341 | 0.070 |
Why?
|
Electric Stimulation | 1 | 2012 | 1742 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2009 | 796 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2012 | 19023 | 0.070 |
Why?
|
Obesity | 3 | 2023 | 13091 | 0.070 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2725 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2006 | 1342 | 0.060 |
Why?
|
Hypnotics and Sedatives | 2 | 2024 | 1191 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10847 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15879 | 0.060 |
Why?
|
Animals | 8 | 2021 | 169335 | 0.060 |
Why?
|
Myoblasts | 1 | 2005 | 234 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 2 | 2012 | 8144 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15471 | 0.060 |
Why?
|
Electrophysiology | 1 | 2006 | 1266 | 0.050 |
Why?
|
Aged | 4 | 2024 | 171786 | 0.050 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1204 | 0.050 |
Why?
|
Adult | 4 | 2024 | 223851 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 2006 | 1526 | 0.040 |
Why?
|
Intestinal Absorption | 1 | 2021 | 400 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1667 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2023 | 1586 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2023 | 81903 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 544 | 0.040 |
Why?
|
Endocrine System Diseases | 1 | 2020 | 250 | 0.040 |
Why?
|
Epinephrine | 1 | 2021 | 794 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6413 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 292 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6291 | 0.040 |
Why?
|
Male | 5 | 2024 | 365203 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3800 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14752 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 60131 | 0.030 |
Why?
|
Brain | 1 | 2024 | 27453 | 0.030 |
Why?
|
Female | 5 | 2024 | 397515 | 0.030 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 628 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2020 | 498 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 74976 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 711 | 0.030 |
Why?
|
Biofilms | 1 | 2020 | 634 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 621 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2006 | 1672 | 0.030 |
Why?
|
Rabbits | 1 | 2021 | 4774 | 0.030 |
Why?
|
Forecasting | 1 | 2024 | 2945 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 744 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59739 | 0.030 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 599 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18354 | 0.030 |
Why?
|
Skin Diseases | 1 | 2020 | 1085 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.020 |
Why?
|
Nutritional Status | 1 | 2020 | 1627 | 0.020 |
Why?
|
Patient Selection | 1 | 2023 | 4265 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2005 | 3301 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4978 | 0.020 |
Why?
|
Nifedipine | 1 | 2010 | 220 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1665 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2020 | 2100 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10765 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 223737 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3683 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8384 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40261 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8894 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2010 | 1090 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2007 | 190 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2474 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7453 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 30265 | 0.010 |
Why?
|
Lidocaine | 1 | 2007 | 546 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14794 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10400 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2007 | 881 | 0.010 |
Why?
|
Potassium | 1 | 2007 | 1315 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15951 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2007 | 1495 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3530 | 0.010 |
Why?
|
HeLa Cells | 1 | 2005 | 3076 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41808 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54962 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15661 | 0.010 |
Why?
|
Mice | 1 | 2010 | 82072 | 0.000 |
Why?
|